Abstract
This chapter examines Major League Baseball's (MLB) drug testing policy under Commissioner Peter Ueberroth, the man who inherited Bowie Kuhn's responsibilities and with them baseball's drug problems. Under Ueberroth's guidance, the league appeared to enjoy a remarkable renaissance. Nevertheless, there was something illusory about the success of Ueberroth's tenure: he struck out on the issue of drugs. This chapter considers Ueberroth's mandatory drug testing policy as part of his campaign to eliminate drugs from baseball in the wake of the Pittsburgh drug trial. It also discusses the league's joint drug policy with the Major League Baseball Players Association (MLBPA), along with the dispute between the union and team owners over the issue of drug testing. The test case for the MLBPA's position would stem from the proliferation of contract clauses requiring voluntary drug testing.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
